EvolutionaryScale develops generative AI models for biology, notably releasing ESM3, a 98-billion-parameter model trained on a dataset of 2.78 billion proteins that can generate and reason about protein sequence, structure, and function. The company offers the full model for non-commercial use via its Forge cloud developer platform and a smaller offline version. EvolutionaryScale plans to monetize through partnerships, usage fees and revenue sharing with researchers and pharma customers. It will make ESM3 available to select AWS customers via SageMaker, Bedrock and HealthOmics and to Nvidia customers via NIM microservices under an enterprise software license, with options to fine-tune using customer data. The firm employs roughly 20 people and acknowledges that translating generative models into therapies could take a decade. EvolutionaryScale aims to scale model training and incorporate data beyond proteins to build general-purpose biotech AI.

Total raised

$142M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2024